Trust Point Inc. Sells 916 Shares of Chemed Co. (NYSE:CHE)

Trust Point Inc. lowered its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 25.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,671 shares of the company's stock after selling 916 shares during the period. Trust Point Inc.'s holdings in Chemed were worth $1,644,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Whipplewood Advisors LLC increased its position in Chemed by 54.5% in the first quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock worth $31,000 after purchasing an additional 18 shares during the last quarter. Impact Capital Partners LLC boosted its stake in Chemed by 2.7% during the first quarter. Impact Capital Partners LLC now owns 763 shares of the company's stock worth $469,000 after buying an additional 20 shares during the period. CIBC Asset Management Inc boosted its stake in Chemed by 5.1% during the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock worth $242,000 after buying an additional 22 shares during the period. CBIZ Investment Advisory Services LLC boosted its stake in shares of Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares during the period. Finally, CIBC Private Wealth Group LLC boosted its stake in shares of Chemed by 13.5% during the fourth quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock valued at $98,000 after purchasing an additional 22 shares during the period. Institutional investors own 95.85% of the company's stock.

Chemed Stock Down 1.4%

CHE opened at $550.29 on Monday. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $623.61. The company has a market cap of $8.05 billion, a P/E ratio of 27.81, a price-to-earnings-growth ratio of 2.15 and a beta of 0.54. The firm's 50-day moving average price is $571.43 and its 200-day moving average price is $565.48.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $646.94 million for the quarter, compared to the consensus estimate of $641.78 million. During the same quarter in the prior year, the company posted $5.20 earnings per share. The company's revenue for the quarter was up 9.8% compared to the same quarter last year. On average, research analysts anticipate that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Thursday, May 29th will be issued a $0.50 dividend. The ex-dividend date is Thursday, May 29th. This represents a $2.00 annualized dividend and a yield of 0.36%. Chemed's dividend payout ratio (DPR) is presently 9.74%.

Insider Buying and Selling

In other Chemed news, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $577.99, for a total value of $866,985.00. Following the sale, the executive vice president now owns 14,627 shares in the company, valued at approximately $8,454,259.73. This represents a 9.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the sale, the chief executive officer now owns 101,679 shares in the company, valued at approximately $62,566,139.07. This represents a 0.97% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,500 shares of company stock worth $3,213,780. 3.29% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Royal Bank of Canada boosted their target price on shares of Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.